Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Cash flows from operating activities:
Net income	$ 1,768,961	$ 3,673,548
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash held in Trust Account	(3,466,643)	(5,016,986)
Changes in operating assets and liabilities:
Prepaid expenses	11,496	66,692
Accounts payable	120,000	86,351
Accrued expenses	580,389	386,100
Advanced by related parties	3,801
Other payables	6,116
Net cash used in operating activities	(975,880)	(804,295)
Cash flows from investing activities:
Cash withdrawn from Trust Account in connection with redemption	32,364,394	43,058,659
Investment of cash in Trust Account	(1,360,000)	(2,940,000)
Net cash provided by investing activities	31,004,394	40,118,659
Cash flows from financing activities:
Redemption of ordinary shares	(32,364,394)	(43,058,659)
Proceeds from working capital loan	833,500	650,000
Proceeds from extension loan	1,360,000	2,940,000
Net cash used in financing activities	(30,170,894)	(39,468,659)
Net change in cash	(142,380)	(154,295)
Cash at the beginning of the period	146,933	301,228
Cash at the end of the period	4,553	146,933
Supplemental disclosure of non-cash investing and financing activities:
Remeasurement of Common Stock subject to redemption	3,466,643	5,016,986
Extension Funds attributable to Common Stock subject to redemption	$ 1,360,000	$ 2,940,000